Our results are similar to those of Adams H., et al., (2009), who performed a microarray analysis of 148 Hodgkin lymphomas and reported an immunophenotype of CD19 (3%), CD20 (30%), CD79a (11%), and PAX5 (37%) [8,23]. This evidence concerns the gene CD19 and Hodgkins lymphoma.